| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.29 | 4e-07 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.27 | 8e-07 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 3e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.17 | 7e-06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.15 | 8e-06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-06 |